Document and Entity Information
Document and Entity Information | Nov. 05, 2020 |
Cover [Abstract] | |
Entity Registrant Name | ANTARES PHARMA, INC. |
Document Type | 8-K |
Amendment Flag | false |
Entity Central Index Key | 0001016169 |
Document Period End Date | Nov. 5, 2020 |
Entity Emerging Growth Company | false |
Entity File Number | 1-32302 |
Entity Incorporation, State or Country Code | DE |
Entity Tax Identification Number | 41-1350192 |
Entity Address, Address Line One | 100 Princeton South |
Entity Address, Address Line Two | Suite 300 |
Entity Address, City or Town | Ewing |
Entity Address, State or Province | NJ |
Entity Address, Postal Zip Code | 08628 |
City Area Code | (609) |
Local Phone Number | 359-3020 |
Written Communications | false |
Soliciting Material | false |
Pre-commencement Tender Offer | false |
Pre-commencement Issuer Tender Offer | false |
Title of 12(b) Security | Common Stock, par value $0.01 per share |
Trading Symbol | ATRS |
Security Exchange Name | NASDAQ |